Cargando…
After the diabetes care trial ends, now what? A 1-year follow-up of the RxING study
INTRODUCTION: There is strong evidence that pharmacist care improves patients’ glycaemic control. However, the sustainability and durability of such interventions beyond the research period is not known. RxING was the first trial of pharmacist prescribing in diabetes and it showed an improvement in...
Autores principales: | Al Hamarneh, Yazid N, Sauriol, Luc, Tsuyuki, Ross T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538249/ https://www.ncbi.nlm.nih.gov/pubmed/26270946 http://dx.doi.org/10.1136/bmjopen-2015-008152 |
Ejemplares similares
-
Pharmacist intervention for glycaemic control in the community (the RxING study)
por: Al Hamarneh, Yazid N, et al.
Publicado: (2013) -
Real-world implementation of diabetes management by pharmacists: The R(X)ING Practice Tool
por: Al Hamarneh, Yazid N., et al.
Publicado: (2021) -
Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop
por: de Ruiter, Ruben D., et al.
Publicado: (2021) -
The effect of nurse practitioner (NP-led) care on health-related quality of life in people with multiple sclerosis – a randomized trial
por: Smyth, Penelope, et al.
Publicado: (2022) -
Impact of a “Pharmacist First” innovative workflow plan in patients with hypertension and/or diabetes
por: So, Randy, et al.
Publicado: (2021)